The fight against sexually transmitted infections (STIs) faces a worrying obstacle: a shortage of the primary drug used to treat syphilis, Benzathine Penicillin G. This critical medication, vital for both treatment and prevention, has become increasingly difficult to obtain for healthcare providers across the United States. This article explores the factors contributing to the shortage,…
